aripiprazole has been researched along with ropinirole in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Dengler, D; Gmeiner, P; Hübner, H; Männel, B; Möller, D; Shonberg, J | 1 |
| Gmeiner, P; Hübner, H; Männel, B; Möller, D | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
| Hettema, JM; Ross, DE | 1 |
| Ameglio, M; Biasci, L; Cecconi, D; Cellesi, V; Forgione, RN; Meini, M; Moncini, M; Pellegrini, M; Rucci, P; Simoni, G | 1 |
| Glenmullen, J; Mattison, DR; Moore, TJ | 1 |
| Canals, M; Capuano, B; Charlton, SJ; Christopoulos, A; Coudrat, T; Donthamsetti, P; Javitch, JA; Klein Herenbrink, C; Lane, JR; Scammells, PJ; Sexton, PM; Shonberg, J; Sykes, DA | 1 |
| Carleton, BC; Etminan, M; Guo, M; Procyshyn, RM; Samii, A; Sodhi, M | 1 |
| Capuano, B; Christopoulos, A; Draper-Joyce, CJ; Javitch, JA; Keen, A; Klein Herenbrink, C; Kopinathan, A; Lane, JR; Lim, HD; Scammells, PJ; Shi, L; Shonberg, J; Verma, R | 1 |
| Håkansson, A; Wolfschlag, M | 1 |
1 review(s) available for aripiprazole and ropinirole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for aripiprazole and ropinirole
| Article | Year |
|---|---|
Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cocaine; Cocaine-Related Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Indoles; Linear Models; Male; Middle Aged; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Young Adult | 2011 |
12 other study(ies) available for aripiprazole and ropinirole
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D
Topics: Animals; beta-Arrestins; CHO Cells; Cricetulus; Dopamine Agonists; Humans; Piperazines; Receptors, Dopamine D2 | 2017 |
β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.
Topics: Antiparkinson Agents; Antipsychotic Agents; beta-Arrestins; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Protein Binding; Receptors, Dopamine D2 | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Female; Humans; Indoles; Middle Aged; Piperazines; Quinolones; Schizophrenia | 2007 |
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration | 2014 |
The role of kinetic context in apparent biased agonism at GPCRs.
Topics: Animals; Aripiprazole; CHO Cells; Cricetulus; Dopamine; Dopamine Agonists; Indoles; Kinetics; Ligands; Piperazines; Piperidines; Principal Component Analysis; Protein Stability; Receptors, Dopamine D2 | 2016 |
Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Canada; Case-Control Studies; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole | 2017 |
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Binding Sites; Dopamine; Dopamine Agonists; Indoles; Ligands; Molecular Conformation; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Receptors, Dopamine D2 | 2019 |
Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
Topics: Adult; Aged; Aged, 80 and over; Aripiprazole; Behavior, Addictive; Cross-Sectional Studies; Dopamine; Dopamine Agonists; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole; Registries; Reward; Risk Factors; Sweden; Young Adult | 2021 |